Market and Trading Information for EPS HOLDINGS INC (Japan)
The following details are available for trading and market data about the stock of EPS HOLDINGS INC as of writing. Currency is JPY.
Current Share Price:
JPY ¥ 1,798.00
Previous Year's Closing Price:
JPY ¥ 976.00
Percentage Price Change (YTD):
84.22%
Market Cap:
JPY ¥ 79.46 billion
52-week Price Range:
937 - 1814
Dividend Per Share:
20
EPS (TTM):
69.32
Price-Earnings (Trailing):
25.94
Price-Earnings (Forward):
15.75
Currency:
JPY
Company Profile and Business Description for EPS HOLDINGS INC
EPS Holdings, Inc., through its subsidiaries, provides outsourced solutions to customers in the healthcare industry. It provides contract research organization (CRO) services and management of CRO segment activities; site management organization services; contract MR services, DI, and other call center services related BPO services, as well as medical device support services; contract sales solutions, including recruitment, training, and development of MRs (permanent, contract staffing, and temp to-perm), as well as medical communications programs and training; and promotion and BPO services for healthcare companies. The company also engages in clinical research related business; provision of IT services for pharmaceutical and medical settings; the import and export of products for non-clinical research, and provision of distribution services; research and development, manufacture, and sale of pharmaceuticals and medical devices; and provision of human studies (functionality and safety evaluations), basic research and animal studies, food composition analysis, research on functional substances, and other research and analysis services, as well as consulting in support of functional food development and other activities. In addition, it engages in trading, investment, and other businesses; shared services; rental and sale of advanced medical and other devices; and sale of clinical trial and other types of life and non-life insurance. The company serves pharmaceutical companies, medical device manufacturers, pharmaceutical development ventures, medical institutions, and universities and research institution in Japan and Asia. EPS Holdings, Inc. was founded in 1991 and is based in Tokyo, Japan.
Stock Screener for Japan Stocks (Sector-wise)
Peer / Competitor Companies of Diagnostics Research Sector of Japan
Along with EPS Holdings, Inc., the following other peer (competitor) companies also exist within the same Diagnostics Research - Healthcare sector of Japan whose company profile and dividend history is as follows:
▶ BML INC (4694): BML, Inc. provides laboratory testing and related services in Japan. The company offers general laboratory tests, including biochemical and....See Detailed Company Profile
▶ CMIC HLDGS Co (2309): CMIC HOLDINGS Co., Ltd. provides various services for the pharmaceutical industry in Japan. The company operates in five segments: Contract....See Detailed Company Profile
▶ COSMO BIO Co (3386): Cosmo Bio Company,Limited engages in the import, export, manufacture, marketing, and sale of life science research biotools that include....See Detailed Company Profile
▶ DNA CHIP RESEARCH (2397): DNA Chip Research Inc. engages in the development of DNA microarrays in Japan. The company is involved in the research and development....See Detailed Company Profile
▶ FALCO HOLDINGS Co (4671): FALCO HOLDINGS Co., Ltd., a medical service company, primarily provides clinical testing and dispensing pharmacy services to medical....See Detailed Company Profile
▶ H.U. GROUP (4544): H.U. Group Holdings, Inc., through its subsidiaries, primarily provides clinical laboratory testing services in Japan. Its clinical laboratory....See Detailed Company Profile
▶ PRECISION SYSTEM SCIENCE CO (7707): Precision System Science Co., Ltd., together with its subsidiaries, develops, manufactures, and sells automated systems/instruments, other....See Detailed Company Profile
▶ SHIN NIPPON BIOMEDICAL LAB (2395): Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, provides drug discovery and development services in Japan and....See Detailed Company Profile
▶ SYSMEX CORP (6869): Sysmex Corporation, together with its subsidiaries, engages in the development, manufacture, and sale of diagnostic instruments, reagents, and....See Detailed Company Profile